Press Releases PYC Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:13 28/06/2024 am IST			5-day change	1st Jan Change
0.12 ^AUD	0.00%		-11.11%	+9.09%

18/06	Canaccord Genuity Starts PYC Therapeutics at Buy With AU$0.22 Price Target	MT
07/06	PYC Therapeutics's Fourth Neurodevelopmental Disorder Drug Candidate Moves Closer to Human Trials; Shares Up 5%	MT

PYC Therapeutics : Corporate Presentation - May 2022	31/22/31	PU
PYC Therapeutics : Q1 Investor Call Presentation	17/22/17	PU
PYC Therapeutics : Notification regarding unquoted securities - PYC	01/22/01	PU
PYC Therapeutics : Quarterly Activities and Appendix 4C Cash Flow Report	27/22/27	PU
PYC Therapeutics : Notification regarding unquoted securities - PYC	30/21/30	PU
PYC Therapeutics : 2021 AGM Chairman's Address and CEO Presentation	18/21/18	PU
Phylogica : Change of Director’s Interest Notice	24/19/24	PU
Phylogica : Scientific Advisory Board Appointment	22/19/22	PU
Phylogica : Collaboration Agreement – siRNA delivery	14/19/14	PU
Phylogica : CEO Letter and Operational Update	17/19/17	PU
Phylogica : In vivo success – peptide vaccine in Herpes Simplex Virus	06/18/06	PU
Phylogica : AGM Company Presentation	16/18/16	PU
Phylogica : R&D Tax Incentive Refund	08/18/08	PU
Phylogica : Reinstatement to Official Quotation	12/18/12	PU
Phylogica : Recapitalisation	12/18/12	PU
Phylogica : Trading Halt	07/18/07	PU
Phylogica : platform described in Nature – Scientific Reports	23/18/23	PU
Phylogica : Delivering Cancer Treatment Inside Cells – Nature Oncogene	06/18/06	PU
Phylogica : Achievement of Major Milestone – In vivo Cre Delivery	30/18/30	PU
Phylogica : Peer Reviewed Journal Publication	16/18/16	PU

No results for this search